Literature DB >> 22743650

The effect of rhBMP-2 on pulmonary arterioles remodeling in endotoxin-induced acute lung injury in rats.

Kunpeng Wang1, Jian Gong, Ling Pei, Shimin Shan, Wenfei Tan.   

Abstract

Endotoxin is known to cause acute lung injury (ALI). Here, we investigated the effects and mechanisms of recombinant human bone morphogenetic protein-2 (rhBMP-2) on pulmonary arteriole remodeling in endotoxin-induced ALI in rats. Sixty Wistar rats were randomly divided into 3 groups (n = 20). Control group was infused with normal saline. Lipopolysaccharides (LPS) alone group was infused with LPS. LPS plus rhBMP2 group was infused with rhBMP-2 and LPS. Lung tissue was harvested. The tunica media of the pulmonary arterioles was measured. The expression levels of survivin, p21, cyclin D1, and activated caspase-3 were examined. The proliferation and apoptosis of pulmonary artery smooth muscle cells were evaluated. The tunica media of pulmonary arterioles in LPS alone group was significantly thicker than both that in control and that in LPS plus rhBMP2 groups (P < 0.01). The multiplication rate in LPS alone group was also significantly higher than both that in control and that in LPS plus rhBMP2 groups (P < 0.01). The apoptotic rate in LPS alone group was lower than that in LPS plus rhBMP2 group (P < 0.01). Compared with the control and LPS plus rhBMP2 groups, the expression levels of mRNA and proteins of survivin and cyclin D1 were increased in LPS alone group (P < 0.01), while the expression levels of p21 and activated caspase-3 were decreased (P < 0.01). RhBMP-2 inhibits the remodeling of pulmonary arterioles in endotoxin-induced ALI, which is achieved by enhancing apoptosis and inhibiting proliferation of pulmonary artery smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743650     DOI: 10.1007/s10238-012-0197-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  14 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  New insights into the pathogenesis and treatment of primary pulmonary hypertension.

Authors:  N Rudarakanchana; R C Trembath; N W Morrell
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Management of acute lung injury and acute respiratory distress syndrome in children: a different perspective.

Authors:  Martin C J Kneyber; Dick G Markhorst
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

4.  Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.

Authors:  Wai K P Wong; James A Knowles; Jane H Morse
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-07       Impact factor: 6.914

5.  How cells cycle toward cancer.

Authors:  J Marx
Journal:  Science       Date:  1994-01-21       Impact factor: 47.728

6.  Bone morphogenetic protein signalling in airway epithelial cells during regeneration.

Authors:  Joanne C Masterson; Emer L Molloy; Jennifer L Gilbert; Natasha McCormack; Aine Adams; Shirley O'Dea
Journal:  Cell Signal       Date:  2010-10-16       Impact factor: 4.315

7.  Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Authors:  Takehiko Dohi; Elena Beltrami; Nathan R Wall; Janet Plescia; Dario C Altieri
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 8.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

9.  Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells.

Authors:  Shen Zhang; Ivana Fantozzi; Donna D Tigno; Eunhee S Yi; Oleksandr Platoshyn; Patricia A Thistlethwaite; Jolene M Kriett; Gordon Yung; Lewis J Rubin; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-05-09       Impact factor: 5.464

10.  Anti-ischaemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1).

Authors:  A M Lefer; P S Tsao; X L Ma; T K Sampath
Journal:  J Mol Cell Cardiol       Date:  1992-06       Impact factor: 5.000

View more
  2 in total

1.  HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling.

Authors:  Huan-Liang Wang; Li-Ping Peng; Wen-Juan Chen; Shu-Hai Tang; Bao-Zhu Sun; Chun-Ling Wang; Rui Huang; Zhi-Jie Xu; Wei-Fu Lei
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.

Authors:  Wei Li; Lu Long; Xudong Yang; Zhen Tong; Mark Southwood; Ross King; Paola Caruso; Paul D Upton; Peiran Yang; Geoffrey A Bocobo; Ivana Nikolic; Angelica Higuera; Richard M Salmon; He Jiang; Katharine M Lodge; Kim Hoenderdos; Rebecca M Baron; Paul B Yu; Alison M Condliffe; Charlotte Summers; Sussan Nourshargh; Edwin R Chilvers; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2021-06-01       Impact factor: 30.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.